首页> 外国专利> Method of manufacturing a medical biodegradable poly-lactic acid by polycondensation of lactic acid catalyzed by creatinine

Method of manufacturing a medical biodegradable poly-lactic acid by polycondensation of lactic acid catalyzed by creatinine

机译:通过肌酸酐催化的乳酸的缩聚制备医用可生物降解的聚乳酸的方法

摘要

The present invention is a method of making a medical biodegradable polylactic acid by direct polycondensation of lactic acid catalyzed by creatinine. In the present invention, as a catalyst (creatinine CR is the product of arginine metabolism in the human body a biomass organic guanidine compounds) creatinine, commercially available, was used as a monomer for industrial lactic acid, the two-step weight solventless by condensation, I get a polylactic acid with high biosafety. In the present invention, without using a Suzu-rui catalyst having cytotoxic polylactic acid catalyst used has the biosafety and biocompatibility advanced, is synthesized does not contain toxic components other and any metal , and suitable carriers targeted drug and the controlled release formulation, the green processes and green catalyst was synthesized biodegradable polylactic advanced biosafety, the obtained raw material cost is likely to be implemented industrially cheap polymerization reaction is easy The molecular weight distribution of the product is small and the molecular weight is controlled within the range of 1.5~3.0 × 10 4. None [Selection Figure]
机译:本发明是通过肌酸酐催化的乳酸的直接缩聚来制备医用生物降解性聚乳酸的方法。在本发明中,作为催化剂(肌酸酐CR是精氨酸在人体中的代谢产物,是一种生物质有机胍化合物),肌酸酐可商购,用作工业乳酸的单体,两步重无溶剂缩合。 ,我得到了具有高生物安全性的聚乳酸。在本发明中,在不使用具有细胞毒性的聚乳酸催化剂的具有生物安全性和生物相容性的先进的Suzu-rui催化剂的情况下,合成不含其他金属和任何有毒成分的,以载体为靶标的药物和控释制剂,绿色流程和绿色催化剂的合成,可生物降解的聚乳酸具有先进的生物安全性,所获得的原料成本很可能在工业上得以实现。廉价的聚合反应容易。产品的分子量分布小,分子量控制在1.5〜3.0× 10 4。无[选择图]

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号